BlackRock Institutional Trust’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.74M Buy
6,429
+16
+0.2% +$5.2K ﹤0.01% 3108
2016
Q3
$2.54M Buy
6,413
+149
+2% +$61.3K ﹤0.01% 2959
2016
Q2
$2.17M Buy
6,264
+485
+8% +$347K ﹤0.01% 3003
2016
Q1
$4.81M Sell
5,779
-51
-0.9% -$40.6K ﹤0.01% 2687
2015
Q4
$6.1M Buy
5,830
+158
+3% +$158K ﹤0.01% 2605
2015
Q3
$4.45M Buy
5,672
+653
+13% +$670K ﹤0.01% 2779
2015
Q2
$6.6M Buy
5,019
+962
+24% +$1.55M ﹤0.01% 2641
2015
Q1
$8.25M Buy
4,057
+1,398
+53% +$3.04M ﹤0.01% 2513
2014
Q4
$5.12M Buy
2,659
+1,706
+179% +$3.03M ﹤0.01% 2723
2014
Q3
$781K Sell
953
-413
-30% -$349K ﹤0.01% 3394
2014
Q2
$1.32M Buy
1,366
+228
+20% +$195K ﹤0.01% 3349
2014
Q1
$1.23M Sell
1,138
-893
-44% -$990K ﹤0.01% 3347
2013
Q4
$1.8M Buy
2,031
+297
+17% +$256K ﹤0.01% 3208
2013
Q3
$1.96M Buy
1,734
+173
+11% +$204K ﹤0.01% 3141
2013
Q2
$1.84M Buy
+1,561
New +$1.48M ﹤0.01% 3121

Other funds holding RGLS